Defining the role for percutaneous mechanical circulatory support devices for medically refractory heart failure

Current Heart Failure Reports

Volumn 10, Issue 2, 2013, Pages 177-184

  Kapur, Navin K ^a   Jumean, Marwan F ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Assist device; Cardiogenic shock; ECMO; Impella; Percutaneous mechanical support; Refractory heart failure; TandemHeart

Indexed keywords

ARTICLE; ASSISTED CIRCULATION; BLOOD FLOW; CENTRIFUGAL PUMP; CLINICAL TRIAL (TOPIC); CORONARY ARTERY BLOOD FLOW; EXTRACORPOREAL OXYGENATION; HEART AFTERLOAD; HEART FAILURE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE OXYGEN CONSUMPTION; HEART OUTPUT; HEART PRELOAD; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE FUNCTION; HUMAN; INTRAAORTIC BALLOON PUMP; LIFE SUPPORT EQUIPMENT; ORGAN PERFUSION; RIGHT VENTRICULAR ASSIST DEVICE;

CLINICAL TRIALS AS TOPIC; EQUIPMENT DESIGN; HEART FAILURE; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS;

EID: 84883053342     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-013-0132-1     Document Type: Article

References (43)

1. Loehr LR, Rosamond WD, Chang PP, Folsom AR, Chambless LE. Heart failure incidence and survival (from the Atherosclerosis Risk in Communities Study). Am J Cardiol. 2008;101:1016-22.
2. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation. 2010;121:e46-e215.
3. Yellon D, Hausenloy D. Myocardial reperfusion injury. NEJM. 2007;357:1121-35.
4. Bregman D, Nichols AB, Weiss MB, Powers ER, Martin EC, Casarella WJ. Percutaneous intraaortic balloon insertion. Am J Cardiol. 1980;46:261-4.
5. Henriques JP, Remmelink M, Baan Jr J, van der Schaaf RJ, Vis MM, Koch KT, et al. Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover Lp 2.5. Am J Cardiol. 2006;97:990-2.
6. Sjauw KD, Remmelink M, Baan Jr J, Lam K, Engstrom AE, van der Schaaf RJ, et al. Left ventricular unloading in acute ST-segment elevation myocardial infarction patients is safe and feasible and provides acute and sustained left ventricular recovery. J Am Coll Cardiol. 2008;51:1044-6.
7. Granada J. Thoractec Percutanous Heart Pump. TCT Conference 2012. www.tctconference.com
8. Thiele H, Lauer B, Hambrecht R, Boudriot E, Cohen HA, Schuler G. Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation. 2001;104:2917-22.
9. Extracorporeal Life Support Organization (ELSO). ECLS registry report, international summary. Ann Arbor: ELSO; 2009.
10. Koeckert MS, Jorde UP, Naka Y, Moses JW, Takayama H. Impella LP 2.5 for left ventricular unloading during venoarterial extracorporeal membrane oxygenation support. J Card Surg. 2011;26(6):666-8.
11. Kantrowitz A, Tionneland S, Freed PS, Phillips SJ, Butner AN, Sherman Jr JL. Initial clinical experience with intra-aortic balloon pumping in cardiogenic shock. JAMA. 1968;203:135-40.
12. •• Patel MR, Smalling RW, Thiele H, Barnhart HX, Zhou Y, Chandra P, et al. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. JAMA. 2011;306(12):1329-37. A recent clinical trial reporting no obvious short-term benefit to pre-reperfusion deployment of an IABP in AMI; however, did identify a trend toward long-term benefit.
13. •• Perera D, Stables R, Clayton T, De Silva K, Lumley M, Clack L. Long-term mortality data from the balloon-pump assisted coronary intervention study (BCIS-1): a randomized controlled trial of elective balloon counterpulsation during high risk PCI. Circulation. 2012 Dec 6 (Epub ahead of print). A recent analysis of the BCIS-1 study showing a statistically significant improvement in mortality with elective IABP insertion during high risk coronary intervention.
14. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367(14):1287-96.
15. Sjauw KD, Konorza T, Erbel R, Danna PL, Viecca M, Minden HH, et al. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry. J Am Coll Cardiol. 2009;54(25):2430-4.
16. Maini B, Naidu SS, Mulukutla S, Kleiman N, Schreiber T, Wohns D, et al. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella registry. Catheter Cardiovasc Interv. 2012;80(5):717-25.
17. Seyfarth M, Sibbing D, Bauer I, Frohlich G, Bott-Flugel L, Byrne R, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intraaortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52:1584-8.
18. O'Neill WW, Kleiman NS, Moses J, Henriques JP, Dixon S, Massaro J, et al. Prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II Study. Circulation. 2012;126(14):1717-27.
19. Griffith BP, Anderson MB, Samuels LE, Pae WE Jr, Naka Y, Frazier OH. The RECOVER I: a multicenter prospective study of Impella 5.0/LD for postcardiotomy circulatory support. J Thorac Cardiovasc Surg. 2012 Mar 9 Epub ahead of print.
20. Burkhoff D, Cohen H, Brunckhorst C, O'Neill WW. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006;152:e1-8.
21. Thiele H, Sick P, Boudriot E, Diederich KW, Hamecht R, Niebauer J, et al. Randomized comparison of intra-aortic balloon support versus a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;26:1276-83.
22. •• Kar B, Gregoric ID, Basra SS, Idelchik GM, Loyalka P. The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol. 2011;57:688-96. Largest reported series of TandemHeart Implants for patients with cardiogenic shock in a single center.
23. Sanborn TA, Sleeper LA, Bates ER, Jacobs AK, Boland J, French JK, et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol. 2000;36:1123-9.
24. •• Cheng JM, den Uil CA, Hoeks SE, van der Ent M, Jewbali LS, van Domburg RT, et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J. 2009;30(17):2102-8. A rare meta-analysis of studies comparing percutaneous mechanical support devices in patients with cardiogenic shock, which showed significant hemodynamic benefit, but no improvement in short-term mortality with percutaneous circulatory support devices when compared to IABP.
25. Combes A, Leprince P, Luyt CE, et al. Outcomes and longterm quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med. 2008;36(5):1404-11.
26. Ghio S, Gavazzi A, Campana C, Inserra C, Klersy C, Sebastiani R, et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol. 2001;37:183-8.
27. Zehender M, Kasper W, Kauder E, Schinthaler M, Geibel A, Olschewski M, et al. Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction. N Engl J Med. 1993;328:981-8.
28. Jacobs AK, Leopold JA, Bates E, Mendes LA, Sleeper LA, White H, et al. Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry. J Am Coll Cardiol. 2003;41:1273-9.
29. Budweiser S, Jörres RA, Riedl T, Heinemann F, Hitzl AP, Windisch W, et al. Predictors of survival in COPD patients with chronic hypercapnic respiratory failure receiving noninvasive home ventilation. Chest. 2007;131(6):1650-8.
30. Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation. 2010;122:164-72.
31. Haddad F, Peterson T, Fuh E, Kudelko KT, de Jesus Perez V, Skhiri M, et al. Characteristics and outcome after hospitalization for acute right heart failure in patients with pulmonary arterial hypertension. Circ Heart Fail. 2011;4:692-9.
32. Apostolakis S, Konstantinides S. The right ventricle in health and disease: insights into physiology, pathophysiology and diagnostic management. Cardiology. 2012;121(4):263-73.
33. Sanchez O, Planquette B, Roux A, Gosset-Woimant M, Meyer G. Triaging in pulmonary embolism. Semin Respir Crit Care Med. 2012;33:156-62.
34. Vlahakes GJ. Right ventricular failure after cardiac surgery. Cardiol Clin. 2012;30(2):283-9.
35. Takagaki M, Wurzer C, Wade R, Lee R, Malaisrie SC, McCarthy PM, et al. Successful conversion of TandemHeart left ventricular assist device to right ventricular assist device after implantation of a HeartMate XVE. Ann Thorac Surg. 2008;86:1677-9.
36. Greyson CR. Pathophysiology of right ventricular failure. Crit Care Med. 2008;36:S57-65.
37. Nordhaug D, Steensrud T, Muller S, Husnes KV, Myrmel T. Intraaortic balloon pumping improves hemodynamics and right ventricular efficiency in acute ischemic right ventricular failure. Ann Thorac Surg. 2004;78(4):1426-32.
38. Atiemo AD, Conte JV, Heldman AW. Resuscitation and recovery from acute right ventricular failure using a percutaneous right ventricular assist device. Catheter Cardiovasc Interv. 2006;68(1):78-82.
39. Takayama H, Naka Y, Kodali SK, Vincent JA, Addonizio LJ, Jorde UP, et al. A novel approach to percutaneous right-ventricular mechanical support. Eur J Cardiothorac Surg. 2012;41(2):423-6.
40. Loor G, Khani-Hanjani A, Gonzalez-Stawinski GV. Use of RotaFlow (MAQUET) for temporary right ventricular support during implantation of HeartMate II left ventricular assist device. ASAIO J. 2012;58(3):275-7.
41. •• Kapur NK, Paruchuri V, Korabathina R, Al-Mohammdi R, Mudd JO, Prutkin J, et al. Effects of a percutaneous mechanical circulatory support device for medically refractory right ventricular failure. J Heart Lung Transplant. 2011;30(12):1360-7. A single center study exploring use of the the TH-RVAD in medically refractory RV failure.
42. Kapur NK, Paruchuri V, Jagannathan A, Finley J, Chakrabarti AK, Steinberg D, et al. Mechanical circulatory support for right ventricular failure: The TandemHeart in RIght VEntricular support (THRIVE) Registry. 32nd IHSLT 2012 Annual Meeting
43. Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, Kormos RL, et al. INTERMACS profiles in advanced heart failure: the current picture. J Heart Lung Transplant 2009;28(6):535-41.